Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter-defibrillator therapy

comment—Authors’ reply

Killu, Ammar M
Cha, Yong-Mei

Division of Heart Rhythm Services, Department of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN, USA

Corresponding author. Tel: 507-538-6325; fax: 507-255-8122. E-mail address: [email protected]

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Online date: November 13, 2018

Europace 21(1):p 179, January 2019. | DOI: 10.1093/europace/euy244